Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
ORIC-114 in Combination With Subcutaneous Amivantamab in Patients With EGFR Exon20 Insertion Mutant NSCLC
Apply
ORIC-114 & Amivantamab
ORIC-114 in Combination With Subcutaneous Amivantamab in Patients With EGFR Exon20 Insertion Mutant NSCLC
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step